Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations-Reference-Cited by-同舟云学术

Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations

Published:2022-12 Issue: Volume:30 Page:101000
ISSN:2451-8654
Container-title:Contemporary Clinical Trials Communications
language:en
Short-container-title:Contemporary Clinical Trials Communications

Author:

Tan W. Katherine^ORCID,Segal Brian D.,Curtis Melissa D.,Baxi Shrujal S.,Capra William B.,Garrett-Mayer Elizabeth^ORCID,Hobbs Brian P.^ORCID,Hong David S.,Hubbard Rebecca A.^ORCID,Zhu Jiawen,Sarkar Somnath,Samant Meghna

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference50 articles.

1. Predicting low accrual in the national cancer institute's cooperative group clinical trials;Bennette;J. Natl. Cancer Inst.,2016

2. A 25-year experience of US food and drug administration accelerated approval of malignant hematology and oncology drugs and biologics: a review;Beaver;JAMA Oncol.,2018

3. Trial designs using real‐world data: the changing landscape of the regulatory approval process;Baumfeld Andre;Pharmacoepidemiol. Drug Saf.,2020

4. Development and validation of a high-quality composite real-world mortality endpoint;Curtis;Health Serv. Res.,2018

5. An exploratory analysis of real-world end points for assessing outcomes among immunotherapy-treated patients with advanced non-small-cell lung cancer;Stewart;JCO Clin Cancer Inform,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization of Real-World Data to Facilitate Clinical Trials for Patients with Lymphoma;Pharmacoepidemiology;2024-08-06

2. Enhancing External Control Arm Analyses through Data Calibration and Hybrid Designs;Clinical Pharmacology & Therapeutics;2024-07-02

3. Intratumoral therapies in head and neck squamous cell carcinoma: A systematic review and future perspectives;Cancer Treatment Reviews;2024-06

4. Estimation of treatment effects in early-phase randomized clinical trials involving external control data;Journal of Biopharmaceutical Statistics;2023-10-12

5. Considerations for pooling real-world data as a comparator cohort to a single arm trial: a simulation study on assessment of heterogeneity;BMC Medical Research Methodology;2023-08-24